Long-term treatment with aspirin desensitization: A prospective clinical trial comparing 100 and 300 mg aspirin daily

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 63, Issue 9, 2008, Pages 1228-1234

  Rozsasi, A ^a   Polzehl, D ^a   Deutschle, T ^a   Smith, E ^a   Wiesmiller, K ^a   Riechelmann, H ^a   Keck, T ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Aspirin; Aspirin desensitization treatment; Nonsteroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; NEDOCROMIL; PLACEBO; PREDNISOLONE; THEOPHYLLINE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESENSITIZATION; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; LONG TERM CARE; LUNG FUNCTION; MALE; NOSE POLYP; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROVOCATION TEST; RECURRENT DISEASE; SMELLING;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL POLYPS; RECURRENCE; RESPIRATORY FUNCTION TESTS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 49249118226     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2008.01658.x     Document Type: Article

References (30)

1. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003 111 : 913 921.
2. Molnar-Gabor E, Endreffy E, Rozsasi A. HLA-DRB1, -DQA1 and -DQB1 genotypes in patients with nasal polyposis. Laryngoscope 2000 110 : 422 425.
3. Weschta M, Rimek D, Formanek M, Polzehl D, Podbielski A, Riechelmann H. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol 2004 113 : 1122 1128.
4. Vento SI, Ertama LO, Hytonen ML, Wolff CH, Malmberg CH. Nasal polyposis: clinical course during 20 years. Ann Allergy Asthma Immunol 2000 85 : 209 214.
5. Albu S, Tomescu E, Mexca Z, Nistor S, Necula S, Cozlean A. Recurrence rates in endonasal surgery for polyposis. Acta Otorhinolaryngol Belg 2004 58 : 79 86.
6. Schapowal AG, Simon HU, Schmitz-Schumann M. Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis. Acta Otorhinolaryngol Belg 1995 49: 235 250.
7. Stevenson DD, Simon RA, Mathison DA. Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges. J Allergy Clin Immunol 1980 66: 82 88.
8. Stevenson DD, Pleskow WW, Simon RA, Mathison DA, Lumry WR, Schatz M et al. Aspirin-sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirin. J Allergy Clin Immunol 1984 73: 500 507.
9. Stevenson DD, Hankammer MA, Mathison DA, Christiansen SC, Simon RA. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol 1996 98: 751 758.
10. Stevenson DD, Suetsugu S. Report of the INTERASMA Working Group on Standardization of Inhalation Provocation Tests in Aspirin-induced Asthma. Oral and inhalation provocation tests for the diagnosis of aspirin-induced asthma. Allergy 2001 56: 899 911.
11. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczynska M, Picado C, Scadding G et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 2007 62: 1111 1118.
12. Berges-Gimeno MP, Simon RA, Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2003 111: 180 186.
13. Lee JY, Simon RA, Stevenson DD. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2007 119: 157 164.
14. Chiu JT. Improvement in aspirin-sensitive asthmatic subjects after rapid aspirin desensitization and aspirin maintenance (ADAM) treatment. J Allergy Clin Immunol 1983 71: 560 567.
15. Kowalski ML, Grzelewska-Rzymowska I, Szmidt M, Rozniecki J. Clinical efficacy of aspirin in "desensitized" aspirin-sensitive asthmatics. Eur J Respir Dis 1986 69: 219 225.
16. Sweet JM, Stevenson DD, Simon RA, Mathison DA. Long-term effects of aspirin desensitization - treatment for aspirin-sensitive rhinosinusitis-asthma. J Allergy Clin Immunol 1990 85: 59 65.
17. Pfaar O, Spielhaupter M, Wrede H, Barth C, Schaefer D, Stuck BA et al. Aspirin desensitization in patients with aspirin intolerance and nasal polyps - a new therapeutic approach by the intravenous route. Allergologie 2006 29: 322 331.
18. Gosepath J, Schaefer D, Amedee RG, Mann WJ. Individual monitoring of aspirin desensitization. Arch Otolaryngol Head Neck Surg 2001 127: 316 321.
19. Patriarca G, Bellioni P, Nucera E, Schiavino D, Papa G, Schinco G et al. Intranasal treatment with lysine acetylsalicylate in patients with nasal polyposis. Ann Allergy 1991 67: 588 592.
20. Parikh AA, Scadding GK. Intranasal lysine-aspirin in aspirin-sensitive nasal polyposis: a controlled trial. Laryngoscope 2005 115: 1385 1390.
21. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG et al. Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med 2000 161: 309 329.
22. Malm L. Assessment and staging of nasal polyposis. Acta Otolaryngol 1997 117: 465 467.
23. Clement PAR, Gordts F. Consensus report on acoustic rhinometry and rhinomanometry. Rhinology 2005 43: 169 179.
24. Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. Sniffin' sticks: olfactory performance assessed by the combined testing of odour identification, odour discrimination and olfactory threshold. Chem Senses 1997 22: 39 52.
25. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Development and validation of the mini rhinoconjunctivitis quality of life questionnaire. Clin Exp Allergy 2000 30: 132 140.
26. Liard R, Leynaert B, Zureik M, Beguin FX, Neukirch F. Using Global Initiative for Asthma guidelines to assess asthma severity in populations. Eur Respir J 2000 16: 615 620.
27. National Heart Lung and Blood Institute. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. NHLBI/VVHO workshop report. Bethesda: National Institutes of Health, 1995. National Heart Lung and Blood Institute publication number 95-3659.
28. Berges-Gimeno MP, Simon RA, Stevenson DD. Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2003 90: 338 341.
29. Keck T, Rozsasi A. Medium-term symptom outcomes after paranasal sinus surgery in children and young adults with cystic fibrosis. Laryngoscope 2007 117: 475 479.
30. Stevenson DD, Woessner KM, Simon RA, Namazy JA, Lang DM. Evidence-based protocols for oral NSAID challenges. J Pediatr 2006 148: 704 705.